Early research (Phase 1)Study completedNCT03894579What this trial is testingAutologous Natural Killer Cells in Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis NKGen Biotech, Inc. 9
Early research (Phase 1)Study completedNCT05990920What this trial is testingStudy of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional TherapyWho this might be right forPathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more NKGen Biotech, Inc. 6
Not applicableStudy completedNCT04366128What this trial is testingCamrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTLWho this might be right forNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Rong Tao 61
Early research (Phase 1)Study completedNCT00900809What this trial is testingQUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia ImmunityBio, Inc. 7
Large-scale testing (Phase 3)WithdrawnNCT07492875What this trial is testingStudy of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired PneumoniaWho this might be right forCommunity-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more ImmunityBio, Inc.
Early research (Phase 1)UnknownNCT06367673What this trial is testingNatural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid LeukemiaWho this might be right forAML, Adult Zhejiang University 24
Not applicableStudy completedNCT03630328What this trial is testingAngelica Gigas Dietary Supplements and Human Immune CellsWho this might be right forInnate Immune Cells Milton S. Hershey Medical Center 15
Early research (Phase 1)UnknownNCT06568328What this trial is testingChimeric Natural Killer Receptor-Universal T Cells for Refractory GVHDWho this might be right forGraft vs Host Disease Fujian Medical University 17
Testing effectiveness (Phase 2)Looking for participantsNCT07480928What this trial is testingDual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease Beijing Biotech 42
Not applicableNot Yet RecruitingNCT05343377What this trial is testingA Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell LymphomaWho this might be right forExtranodal Natural Killer/T-cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 72
Testing effectiveness (Phase 2)Looking for participantsNCT07635056What this trial is testingHaploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory NeuroblastomaWho this might be right forNeuroblastoma Children's Hospital Medical Center, Cincinnati 20
Early research (Phase 1)Study completedNCT03941262What this trial is testingSafety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyWho this might be right forRefractory CancerMetastatic CancerRecurrent Cancer+4 more NKGen Biotech, Inc. 27
Not applicableUnknownNCT02963155What this trial is testingStudy of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to CastrationWho this might be right forMetastatic Prostate Cancer Institut Paoli-Calmettes 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783478What this trial is testingNK Cell Infusion for Remission Consolidation in AML: A Phase II TrialWho this might be right forAcute Myeloid Leukaemia (AML) Hospital de Clinicas de Porto Alegre 98
Testing effectiveness (Phase 2)UnknownNCT01178658What this trial is testingStudy of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell LymphomaWho this might be right forNon-Hodgkin Lymphoma Seoul National University Hospital 42
Early research (Phase 1)Study completedNCT02280525What this trial is testingCord Blood Natural Killer (NK) Cells in Leukemia/LymphomaWho this might be right forLeukemia M.D. Anderson Cancer Center 8
Not applicableLooking for participantsNCT06885476What this trial is testingInfusion of Alloreactive nk Cells for Mrd-positive Aml PatientsWho this might be right forAcute Myeloid LeukemiaMinimal Residual DiseaseNatural Killer Cell IRCCS Azienda Ospedaliero-Universitaria di Bologna 22
Very early researchNot Yet RecruitingNCT07709299What this trial is testingSafety and Feasibility of CIK Cell Therapy in HCC After Tumor ResectionWho this might be right forHepatocellular Carcinoma (HCC) Royan Institute 6
Not applicableStudy completedNCT06320392What this trial is testingImplication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Ain Shams University 90
Early research (Phase 1)Active Not RecruitingNCT06325748What this trial is testingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSWho this might be right forAML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies Senti Biosciences 21